Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $14.02 billion. The enterprise value is $12.76 billion.
| Market Cap | 14.02B |
| Enterprise Value | 12.76B |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026, after market close.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 251.36 million shares outstanding. The number of shares has decreased by -5.19% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 251.36M |
| Shares Change (YoY) | -5.19% |
| Shares Change (QoQ) | -3.27% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 89.51% |
| Float | 204.47M |
Valuation Ratios
The trailing PE ratio is 18.45 and the forward PE ratio is 16.79. Exelixis's PEG ratio is 1.53.
| PE Ratio | 18.45 |
| Forward PE | 16.79 |
| PS Ratio | 5.90 |
| Forward PS | 5.22 |
| PB Ratio | 7.31 |
| P/TBV Ratio | 7.49 |
| P/FCF Ratio | 15.28 |
| P/OCF Ratio | 15.16 |
| PEG Ratio | 1.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.94, with an EV/FCF ratio of 13.91.
| EV / Earnings | 15.31 |
| EV / Sales | 5.37 |
| EV / EBITDA | 12.94 |
| EV / EBIT | 13.33 |
| EV / FCF | 13.91 |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.26 |
| Quick Ratio | 3.01 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.18 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 40.99% and return on invested capital (ROIC) is 60.44%.
| Return on Equity (ROE) | 40.99% |
| Return on Assets (ROA) | 22.03% |
| Return on Invested Capital (ROIC) | 60.44% |
| Return on Capital Employed (ROCE) | 43.07% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | $2.21M |
| Profits Per Employee | $773,836 |
| Employee Count | 1,077 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 3.28 |
Taxes
In the past 12 months, Exelixis has paid $169.78 million in taxes.
| Income Tax | 169.78M |
| Effective Tax Rate | 16.92% |
Stock Price Statistics
The stock price has increased by +24.32% in the last 52 weeks. The beta is 0.42, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +24.32% |
| 50-Day Moving Average | 51.65 |
| 200-Day Moving Average | 44.76 |
| Relative Strength Index (RSI) | 59.38 |
| Average Volume (20 Days) | 2,905,797 |
Short Selling Information
The latest short interest is 28.54 million, so 11.35% of the outstanding shares have been sold short.
| Short Interest | 28.54M |
| Short Previous Month | 30.64M |
| Short % of Shares Out | 11.35% |
| Short % of Float | 13.96% |
| Short Ratio (days to cover) | 10.18 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.38 billion and earned $833.42 million in profits. Earnings per share was $3.02.
| Revenue | 2.38B |
| Gross Profit | 2.29B |
| Operating Income | 957.18M |
| Pretax Income | 1.00B |
| Net Income | 833.42M |
| EBITDA | 985.84M |
| EBIT | 957.18M |
| Earnings Per Share (EPS) | $3.02 |
Balance Sheet
The company has $777.21 million in cash and $169.54 million in debt, with a net cash position of $1.26 billion or $5.00 per share.
| Cash & Cash Equivalents | 777.21M |
| Total Debt | 169.54M |
| Net Cash | 1.26B |
| Net Cash Per Share | $5.00 |
| Equity (Book Value) | 1.94B |
| Book Value Per Share | 7.63 |
| Working Capital | 837.66M |
Cash Flow
In the last 12 months, operating cash flow was $924.68 million and capital expenditures -$6.99 million, giving a free cash flow of $917.69 million.
| Operating Cash Flow | 924.68M |
| Capital Expenditures | -6.99M |
| Depreciation & Amortization | 28.66M |
| Net Borrowing | n/a |
| Free Cash Flow | 917.69M |
| FCF Per Share | $3.65 |
Margins
Gross margin is 96.44%, with operating and profit margins of 40.29% and 35.08%.
| Gross Margin | 96.44% |
| Operating Margin | 40.29% |
| Pretax Margin | 42.23% |
| Profit Margin | 35.08% |
| EBITDA Margin | 41.50% |
| EBIT Margin | 40.29% |
| FCF Margin | 38.63% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.19% |
| Shareholder Yield | 5.19% |
| Earnings Yield | 5.95% |
| FCF Yield | 6.55% |
Analyst Forecast
The average price target for Exelixis is $51.19, which is -8.21% lower than the current price. The consensus rating is "Buy".
| Price Target | $51.19 |
| Price Target Difference | -8.21% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | 11.82% |
| EPS Growth Forecast (3Y) | 13.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 12.52 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.52 |
| Piotroski F-Score | 5 |